Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In this issue of JEM, Shakiba et al. (2021. J. Exp. Med. https://doi.org/10.1084/jem.20201966) tell a tale of three tumor infiltrating lymphocytes (TILs). The first TIL was too strong and became exhausted. The second TIL was too weak and became inert. The third TIL lost CD8, and this made it just right.

Original publication

DOI

10.1084/jem.20212269

Type

Report

Publication Date

02/2022

Volume

219

Addresses

National lnstitutes of Health Oxford-Cambridge Scholars Program, Center for Cancer Research, National Cancer Institute, National lnstitutes of Health, Bethesda, MD.

Keywords

Lymphocytes, Tumor-Infiltrating